Exozymes VP granted 45,000 stock options
EXOZYMES INC.’s Vice President–Finance received a 45,000-share stock option award vesting quarterly over three years.
Rhea-AI Filing Summary
EXOZYMES INC. (EXOZ) reported that Vice President–Finance Nawaz Fouad received a grant of stock options for 45,000 shares of common stock on September 14, 2026, at an exercise price of $6.28 per share. These options vest over three years in twelve equal quarterly installments of 3,750 shares, beginning with the first full calendar quarter after the grant, with the first installment vesting on December 31, 2026 and the final installment on September 30, 2029. The options expire on September 14, 2033. Following this award, Fouad also holds 9,488 shares of common stock directly, and no transactions are reported under any Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 45,000 shares
Grant/Award
2 txns
Insider
Nawaz Fouad
Role
Vice President- Finance
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 45,000 | $0.00 | $0.00 |
| holding | COMMON STOCK | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 45,000 contracts (Direct);
COMMON STOCK — 9,488 shares (Direct)
Footnotes (1)
- F1. The option vests over a three (3) year period in twelve (12) equal quarterly installments of 3,750 shares at the end of each quarter of the calendar year, commencing with the first full calendar quarter following the date of grant. The first installment vests on 12/31/2026 and the final installment vests on 09/30/2029. The option expires on 09/14/2033.
Key Figures
Stock options granted: 45,000 options for common stock
Exercise price: $6.28 per share
Vesting installments: 3,750 shares per quarter
+4 more
7 metrics
Stock options granted
45,000 options for common stock
Grant to Vice President–Finance on September 14, 2026
Exercise price
$6.28 per share
Exercise price of the 45,000 stock options granted September 14, 2026
Vesting installments
3,750 shares per quarter
Twelve equal quarterly installments over three years
Vesting period start
December 31, 2026
First installment of the option vesting schedule
Vesting period end
September 30, 2029
Final installment of the option vesting schedule
Option expiration date
September 14, 2033
Expiration of the 45,000-share stock option award
Common shares held
9,488 shares
Direct common stock holdings after the reported transactions
Key Terms
Stock Option (right to buy), vesting, exercise price, Common Stock
4 terms
Stock Option (right to buy) financial
"Stock Option (right to buy)"
vesting financial
"The option vests over a three (3) year period in twelve (12) equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion or exercise price of 6.2800 per share for the option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Common Stock financial
"underlying security title Common Stock for the 45,000-share option grant"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did EXOZ (EXOZYMES INC.) report for Nawaz Fouad?
EXOZYMES INC. reported that Vice President–Finance Nawaz Fouad received a grant of stock options for 45,000 shares of common stock on September 14, 2026, with an exercise price of $6.28 per share, expiring on September 14, 2033.
What is the vesting schedule of the 45,000 stock options granted at EXOZ?
The 45,000 stock options vest over a three-year period in twelve equal quarterly installments of 3,750 shares, starting with the first full calendar quarter after the grant. The first installment vests on December 31, 2026, and the final installment vests on September 30, 2029.
What is the exercise price and expiration date of Nawaz Fouad’s options at EXOZ?
The stock options granted to Nawaz Fouad have an exercise price of $6.28 per share and expire on September 14, 2033, giving him the right to buy EXOZ common shares at that price until that date, subject to vesting.
Was the EXOZ insider option grant to Nawaz Fouad under a Rule 10b5-1 trading plan?
No. The filing indicates that the grant of 45,000 stock options to Nawaz Fouad on September 14, 2026 was not made pursuant to a Rule 10b5-1 trading plan, based on the unchecked plan status in the report.
What role does Nawaz Fouad hold at EXOZYMES INC. in this Form 4?
In this Form 4, Nawaz Fouad is identified as Vice President–Finance of EXOZYMES INC., and the reported transactions relate to his compensation-related stock option award and his direct holdings of EXOZ common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
